c-Abl Tyrosine Kinase Regulates the Human Rad9 Checkpoint Protein in Response to DNA Damage

REFERENCES

• Adams, J. M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322–1326.
   PubMed Web of Science ®Google Scholar
• Agami, R., G. Blandino, M. Oren, and Y. Shaul. 1999. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature 399: 809–813.
   PubMed Web of Science ®Google Scholar
• al-Khodairy, F., and A. M. Carr. 1992. DNA repair mutants defining G2 checkpoint pathways in Schizosaccharomyces pombe. EMBO J. 11: 1343–1350.
   PubMed Web of Science ®Google Scholar
• al-Khodairy, F., E. Fotou, K. S. Sheldrick, D. J. Griffiths, A. R. Lehmann, and A. M. Carr. 1994. Identification and characterization of new elements inv olved in checkpoint and feedback controls in fission yeast. Mol. Biol. Cell 5: 147–160.
   PubMed Web of Science ®Google Scholar
• Baskaran, R., L. D. Wood, L. L. Whitaker, Y. Xu, C. Barlow, C. E. Canman, S. E. Morgan, D. Baltimore, A. Wynshaw-Boris, M. B. Kastan, and J. Y. J. Wang. 1997. Ataxia telangiectasia mutant protein activates c-abl tyrosine kinase in response to ionizing radiation. Nature 387: 516–519.
   PubMed Web of Science ®Google Scholar
• Bessho, T., and A. Sancar. 2000. Human DNA damage checkpoint protein hRAD9 is a 3′ to 5′ exonuclease. J. Biol. Chem. 275: 7451–7454.
   PubMedGoogle Scholar
• Burtelow, M. A., S. H. Kaufmann, and L. M. Karnitz. 2000. Retention of the human Rad9 checkpoint complex in extraction-resistant nuclear complexes after DNA damage. J. Biol. Chem. 275: 26343–26348.
   PubMedGoogle Scholar
• Chen, Y.-R., X. Wang, D. Templeton, R. J. Davis, and T.-H. Tan. 1996. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J. Biol. Chem. 271: 31929–31936.
   PubMed Web of Science ®Google Scholar
• Datta, R., Y. Manome, N. Taneja, L. H. Boise, R. R. Weichselbaum, C. B. Thompson, C. A. Slapak, and D. W. Kufe. 1995. Overexpression of Bcl-xL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. Cell Growth Differ. 6: 363–370.
   PubMedGoogle Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475–1489.
   PubMed Web of Science ®Google Scholar
• Druker, B. J., S. Tamura, E. Buchdunger, S. Ohno, G. M. Segal, S. Fanning, J. Zimmermann, and N. B. Lydon. 1996. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2: 561–566.
   PubMed Web of Science ®Google Scholar
• Feller, S. M., B. Knudsen, and H. Hanafusa. 1994. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13: 2341–2351.
   PubMed Web of Science ®Google Scholar
• Fram, R. J., and D. Kufe. 1982. DNA strand breaks caused by inhibitors of DNA synthesis: 1-β-D-arabinofuranosylcytosine and aphidicolin. Cancer Res. 42: 4050–4053.
   PubMed Web of Science ®Google Scholar
• Freire, R., J. R. Murguia, M. Tarsounas, N. F. Lowndes, P. B. Moens, and S. P. Jackson. 1998. Human and mouse homologs of Schizosaccharomyces pombe rad1(+) and Saccharomyces cerevisiae RAD17: linkage to checkpoint control and mammalian meiosis. Genes Dev. 12: 2560–2573.
   PubMedGoogle Scholar
• Gong, J., A. Costanzo, H. Yang, G. Melino, W. Kaelin, Jr., M. Levrero, and J. Y. J. Wang. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806–809.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Z. M. Yuan, T. Ishiko, S. Nakada, T. Utsugisawa, T. Kato, S. Kharbanda, and D. W. Kufe. 1997. Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-β-D-arabinofuranosylcytosine. Oncogene 15: 1947–1952.
   PubMedGoogle Scholar
• Jin, S., S. Kharbanda, B. Mayer, D. Kufe, and D. T. Weaver. 1997. Binding of Ku and c-Abl at the kinase homology region of DNA-dependent protein kinase catalytic subunit. J. Biol. Chem. 272: 24763–24766.
   PubMed Web of Science ®Google Scholar
• Kelekar, A., and C. B. Thompson. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8: 324–330.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., P. Pandey, S. Jin, S. Inoue, A. Bharti, Z.-M. Yuan, R. Weichselbaum, D. Weaver, and D. Kufe. 1997. Functional interaction of DNA-PK and c-Abl in response to DNA damage. Nature 386: 732–735.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., P. Pandey, R. Ren, S. Feller, B. Mayer, L. Zon, and D. Kufe. 1995. c-Abl activation regulates induction of the SEK1/stress activated protein kinase pathway in the cellular response to 1-β-D-arabinofuranosylcytosine. J. Biol. Chem. 270: 30278–30281.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., P. Pandey, L. Schofield, S. Israels, R. Roncinske, K. Yoshida, A. Bharti, Z. Yuan, S. Saxena, R. Weichselbaum, C. Nalin, and D. Kufe. 1997. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in apoptosis. Proc. Natl. Acad. Sci. USA 94: 6939–6942.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., P. Pandey, T. Yamauchi, S. Kumar, M. Kaneki, V. Kumar, A. Bharti, Z. Yuan, L. Ghanem, A. Rana, R. Weichselbaum, G. Johnson, and D. Kufe. 2000. Activation of MEK kinase-1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol. Cell. Biol. 20: 4979–4989.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., R. Ren, P. Pandey, T. D. Shafman, S. M. Feller, R. R. Weichselbaum, and D. W. Kufe. 1995. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785–788.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., S. Saxena, K. Yoshida, P. Pandey, M. Kaneki, Q. Wang, K. Cheng, Y. Chen, A. Campbell, S. Thangrila, Z. Yuan, J. Narula, R. Weichselbaum, C. Nalin, and D. Kufe. 2000. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-xL in response to DNA damage. J. Biol. Chem. 275: 322–327.
   PubMed Web of Science ®Google Scholar
• Kharbanda, S., Z. Yuan, R. Weichselbaum, and D. Kufe. 1998. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17: 3309–3318.
   PubMed Web of Science ®Google Scholar
• Komatsu, K., K. M. Hopkins, H. B. Lieberman, and H. Wang. 2000. Schizosaccharomyces pombe Rad9 contains a BH3-like region and interacts with the anti-apoptotic protein Bcl-2. FEBS Lett. 481: 122–126.
   PubMedGoogle Scholar
• Komatsu, K., T. Miyashita, H. Hang, K. M. Hopkins, W. Zheng, S. Cuddeback, M. Yamada, H. B. Lieberman, and H. G. Wang. 2000. Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat. Cell Biol. 2: 1–6.
   PubMed Web of Science ®Google Scholar
• Komatsu, K., W. Wharton, H. Hang, C. Wu, S. Singh, H. Lieberman, W. Pledger, and H. Wang. 2000. PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition. Oncogene 19: 5291–5297.
   PubMed Web of Science ®Google Scholar
• Kostrub, C. F., K. Knudsen, S. Subramani, and T. Enoch. 1998. Hus1p, a conserved fission yeast checkpoint protein, interacts with Rad1p and is phosphorylated in response to DNA damage. EMBO J. 17: 2055–2066.
   PubMedGoogle Scholar
• Kruh, G. D., R. Perego, T. Miki, and S. A. Aaronson. 1990. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl. Acad. Sci. USA 87: 5802–5806.
   PubMed Web of Science ®Google Scholar
• Kufe, D. W., P. P. Major, E. M. Egan, and G. P. Beardsley. 1980. Correlation of cytotoxicity with incorporation of ara-C into DNA. J. Biol. Chem. 255: 8997–9000.
   PubMed Web of Science ®Google Scholar
• Lieberman, H. B., K. M. Hopkins, M. Nass, D. Demetrick, and S. Davey. 1996. A human homolog of the Schizosaccharomyces pombe rad9+ checkpoint control gene. Proc. Natl. Acad. Sci. USA 93: 13890–13895.
   PubMedGoogle Scholar
• Mayer, B. J., and D. Baltimore. 1994. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase. Mol. Cell. Biol. 14: 2883–2894.
   PubMed Web of Science ®Google Scholar
• Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65: 2220–2224.
   PubMedGoogle Scholar
• Muchmore, S. W., M. Sattler, H. Liang, R. P. Meadows, J. E. Harlan, H. S. Yoon, D. Nettesheim, B. S. Chang, C. B. Thompson, S.-L. Wong, S.-C. Ng, and S. W. Fesik. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335–341.
   PubMed Web of Science ®Google Scholar
• Ohno, Y., D. Spriggs, A. Matsukage, T. Ohno, and D. Kufe. 1988. Effects of 1-β-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase β. Cancer Res. 48: 1494–1498.
   PubMed Web of Science ®Google Scholar
• Pandey, P., J. Raingeaud, M. Kaneki, R. Weichselbaum, R. Davis, D. Kufe, and S. Kharbanda. 1996. Activation of p38 MAP kinase by c-Abl-dependent and -independent mechanisms. J. Biol. Chem. 271: 23775–23779.
   PubMedGoogle Scholar
• Parker, A. E., I. van de Weyer, M. C. Laus, I. Oostveen, J. Yon, P. Verhasselt, and W. H. Luyten. 1998. A human homologue of the Schizosaccharomyces pombe rad1+ checkpoint gene encodes an exonuclease. J. Biol. Chem. 273: 18332–18339.
   PubMedGoogle Scholar
• Raitano, A. B., J. R. Halpern, T. M. Hambuch, and C. L. Sawyers. 1995. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc. Natl. Acad. Sci. USA 92: 11746–11750.
   PubMed Web of Science ®Google Scholar
• Ren, R., Z. Ye, and D. Baltimore. 1994. Abl protein-tyrosine kinase selects the Crk adaptor as a substrate using SH3-binding sites. Genes Dev. 8: 783–795.
   PubMed Web of Science ®Google Scholar
• Renshaw, M. W., E. Lea-Chou, and J. Y. J. Wang. 1996. Rac is required for v-Abl tyrosine kinase to activate mitogenesis. Curr. Biol. 6: 76–83.
   PubMedGoogle Scholar
• Sanchez, Y., C. Wong, R. S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms, and S. J. Elledge. 1997. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277: 1497–1501.
   PubMed Web of Science ®Google Scholar
• Sattler, M., R. Salgia, K. Okuda, N. Uemura, M. A. Durstin, E. Pisick, G. Xu, J. L. Li, K. V. Prasad, and J. D. Griffin. 1996. The proto-oncogene product p120BCR/ABL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3′ kinase pathway. Oncogene 12: 839–846.
   PubMed Web of Science ®Google Scholar
• Shafman, T., K. K. Khanna, P. Kedar, K. Spring, S. Kozlov, T. Yen, K. Hobson, M. Gatei, N. Zhang, D. Watters, M. Egerton, Y. Shiloh, S. Kharbanda, D. Kufe, and M. F. Lavin. 1997. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387: 520–523.
   PubMed Web of Science ®Google Scholar
• St. Onge, R. P., C. M. Udell, R. Casselman, and S. Davey. 1999. The human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1. Mol. Biol. Cell 10: 1985–1995.
   PubMedGoogle Scholar
• Till, J. H., P. M. Chan, and W. T. Miller. 1999. Engineering the substrate specificity of the Abl tyrosine kinase. J. Biol. Chem. 274: 4995–5003.
   PubMed Web of Science ®Google Scholar
• Tybulewicz, V. L. J., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153–1163.
   PubMed Web of Science ®Google Scholar
• Udell, C. M., S. K. Lee, and S. Davey. 1998. RAD1 and MRAD1 encode mammalian homologues of the fission yeast rad1(+) cell cycle checkpoint control gene. Nucleic Acids Res. 26: 3971–3976.
   PubMedGoogle Scholar
• Verheij, M., R. Bose, X. H. Lin, B. Yhao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, A. Haimovitz-Friedman, Z. Fuks, and R. N. Kolesnick. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75–79.
   PubMed Web of Science ®Google Scholar
• Volkmer, E., and L. M. Karnitz. 1999. Human homologs of Schizosaccharomyces pombe rad1, hus1, and rad9 form a DNA damage-responsive protein complex. J. Biol. Chem. 274: 567–570.
   PubMedGoogle Scholar
• Wang, K., X. M. Yin, D. T. Chao, C. L. Milliman, and S. J. Korsmeyer. 1996. BID: a novel BH3 domain-only death agonist. Genes Dev. 10: 2859–2869.
   PubMed Web of Science ®Google Scholar
• Yoshida, K., S. Kharbanda, and D. Kufe. 1999. Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage. J. Biol. Chem. 274: 34663–34668.
   PubMed Web of Science ®Google Scholar
• Yoshida, K., R. Weichselbaum, S. Kharbanda, and D. Kufe. 2000. Role for the Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage. Mol. Cell. Biol. 20: 5370–5380.
   PubMed Web of Science ®Google Scholar
• Yuan, Z., Y. Huang, M. Fan, C. Sawers, S. Kharbanda, and D. Kufe. 1996. Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53. J. Biol. Chem. 271: 26457–26460.
   PubMedGoogle Scholar
• Yuan, Z., Y. Huang, T. Ishiko, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1997. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94: 1437–1440.
   PubMed Web of Science ®Google Scholar
• Yuan, Z. M., Y. Huang, T. Ishiko, S. Nakada, T. Utsugisawa, S. Kharbanda, P. Sung, A. Shinohara, R. Weichselbaum, and D. Kufe. 1998. Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273: 3799–3802.
   PubMedGoogle Scholar
• Yuan, Z. M., Y. Huang, Y. Whang, C. Sawyers, R. Weichselbaum, S. Kharbanda, and D. Kufe. 1996. Role for the c-Abl tyrosine kinase in the growth arrest response to DNA damage. Nature 382: 272–274.
   PubMed Web of Science ®Google Scholar
• Yuan, Z. M., H. Shioya, T. Ishiko, X. Sun, Y. Huang, H. Lu, S. Kharbanda, R. Weichselbaum, and D. Kufe. 1999. p73 is regulated by the c-Abl tyrosine kinase in the apoptotic response to DNA damage. Nature 399: 814–817.
   PubMed Web of Science ®Google Scholar
• Zha, J., H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer. 1996. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87: 619–628.
   PubMed Web of Science ®Google Scholar
• Zhou, S., K. L. Carraway, M. J. Eck, S. C. Harrison, R. A. Feldman, M. Mohammadi, J. Schlessinger, S. R. Hubbard, D. P. Smith, and C. Eng. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373: 536–539.
   PubMedGoogle Scholar